Jake Bauer

CIK: 0001654909

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

BBOT

BridgeBio Oncology Therapeutics, Inc.

Director

IMVT

Immunovant, Inc.

Director

ELVN

Enliven Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

BBOT
BridgeBio Oncology Therapeutics, Inc.
Jun 16, 2026
Award(A)
Stock Option (Right to Buy)
Direct
31.7K shares-
IMVT
Immunovant, Inc.
Apr 7, 2026
Award(A)
Direct
13.9K shares-
ELVN
Enliven Therapeutics, Inc.
Feb 12, 2026
Award(A)
Stock Option (right to buy)
Direct
17.1K shares-
BBOT
BridgeBio Oncology Therapeutics, Inc.
Aug 26, 2025
Award(A)
Stock Option (Right to Buy)
Direct
138.2K shares-
IMVT
Immunovant, Inc.
May 1, 2025
Award(A)
Direct
25K shares-
ELVN
Enliven Therapeutics, Inc.
Feb 6, 2025
Award(A)
Stock Option (right to buy)
Direct
20.5K shares-

		Type	Shares	Price		Ownership
Jun 16, 2026	BBOT BridgeBio Oncology Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	31,675	-	-	Direct
Apr 7, 2026	IMVT Immunovant, Inc.	Award(A)	13,880	-	$0	Direct
Feb 12, 2026	ELVN Enliven Therapeutics, Inc.	Award(A) Stock Option (right to buy)	17,126	-	-	Direct
Aug 26, 2025	BBOT BridgeBio Oncology Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	138,193	-	-	Direct
May 1, 2025	IMVT Immunovant, Inc.	Award(A)	25,016	-	-	Direct
Feb 6, 2025	ELVN Enliven Therapeutics, Inc.	Award(A) Stock Option (right to buy)	20,491	-	-	Direct

1-6 of 6 transactions

About Bauer Jake

Bauer Jake (SEC CIK 0001654909) files insider reports with the SEC as Director of BridgeBio Oncology Therapeutics, Inc. (BBOT), Director of Immunovant, Inc. (IMVT) and Director of Enliven Therapeutics, Inc. (ELVN).

Signal8 holds 8 ownership filings by Bauer Jake (2 Form 3, 6 Form 4), filed between Feb 10, 2025 and Jun 18, 2026. Those filings report 6 transactions, from Feb 6, 2025 to Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Bauer Jake's filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Bauer Jake

Jun 16, 2026: Grant or award of BBOT derivative securities (Form 4, code A).
Apr 7, 2026: Grant or award of IMVT shares (Form 4, code A).
Feb 12, 2026: Grant or award of ELVN derivative securities (Form 4, code A).
Aug 26, 2025: Grant or award of BBOT derivative securities (Form 4, code A).
May 1, 2025: Grant or award of IMVT shares (Form 4, code A).

Other insiders filing for BridgeBio Oncology Therapeutics, Inc. (BBOT)

Cobo Marc, Principal Accounting Officer
Elmelech Idan, COO & Principal Financial Ofcr
Beltran Pedro, President and CEO
Ben Yong, Chief Med & Dev Officer
Chen Bihua, Director
Tipirneni Praveen P., Director

How to read Form 4 transaction codes